Home/Filings/4/0001192482-18-000049
4//SEC Filing

Graff Fred 4

Accession 0001192482-18-000049

CIK 0001588972other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:03 PM ET

Size

8.3 KB

Accession

0001192482-18-000049

Insider Transaction Report

Form 4
Period: 2018-01-18
Graff Fred
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-18+6,00028,900 total
  • Exercise/Conversion

    Restricted Stock Units

    2018-01-186,00018,000 total
    Common Stock (6,000 underlying)
  • Tax Payment

    Common Stock

    2018-01-18$8.89/sh1,817$16,15327,083 total
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On January 18, 2017, the reporting person was granted 24,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeother

Related Parties

1
  • filerCIK 0001667407

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:03 PM ET
Size
8.3 KB